Switch to:
More From Other Websites
3 Highly Rated IBD Stocks Powering A Top Biotech ETF’s Revival May 27 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission... May 25 2016
LIGAND PHARMACEUTICALS INC Financials May 18 2016
VKTX: Phase 2 Study of VK5211 for Hip Fracture Ongoing; Phase 2 Study of VK2809 for... May 16 2016
Intec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors May 16 2016
ETF’s with exposure to Ligand Pharmaceuticals, Inc. : May 9, 2016 May 09 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... May 09 2016
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q1, 2016 By the Numbers May 05 2016
Ligand (LGND) Tops Q1 Earnings, Revenues, Updates View May 05 2016
IBD 50: Ligand Pharma Beats Q1 Estimates, Buys Device Royalties May 04 2016
Ligand (LGND) Beats Q1 Earnings and Revenue Estimates May 04 2016
Ligand Pharmaceuticals Q1 Adjusted Earnings Beat May 04 2016
Q1 2016 Ligand Pharmaceuticals Inc Earnings Release - Before Market Open May 04 2016
Ligand tops 1Q revenue forecasts May 04 2016
Ligand tops 1Q revenue forecasts May 04 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement May 04 2016
Ligand Reports First Quarter 2016 Financial Results May 04 2016
Ligand Acquires Portfolio of Synthetic Royalty and Milestone Rights from CorMatrix® Cardiovascular... May 04 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK